{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:53:55Z","timestamp":1792796035253,"version":"4.5.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"41","license":[{"start":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T00:00:00Z","timestamp":1724371200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T00:00:00Z","timestamp":1724371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100009323","name":"Animal Free Research UK","doi-asserted-by":"publisher","award":["AFR19-20366"],"award-info":[{"award-number":["AFR19-20366"]}],"id":[{"id":"10.13039\/501100009323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009323","name":"Animal Free Research UK","doi-asserted-by":"publisher","award":["AFR19-20366"],"award-info":[{"award-number":["AFR19-20366"]}],"id":[{"id":"10.13039\/501100009323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009323","name":"Animal Free Research UK","doi-asserted-by":"publisher","award":["AFR19-20366"],"award-info":[{"award-number":["AFR19-20366"]}],"id":[{"id":"10.13039\/501100009323","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Brain Tumour Research https:\/\/braintumourresearch.org\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2024,10,7]]},"DOI":"10.1038\/s41388-024-03131-z","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T20:45:53Z","timestamp":1724445953000},"page":"3049-3061","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Targeting MERTK on tumour cells and macrophages: a potential intervention for sporadic and NF2-related meningioma and schwannoma tumours"],"prefix":"10.1038","volume":"43","author":[{"given":"Foram","family":"Dave","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Lockley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurien L.","family":"van de Weijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Summer","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agbolahan A.","family":"Sofela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Hook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire L.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Ercolano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Hilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel A.","family":"Maze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathreena M.","family":"Kurian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1525-3583","authenticated-orcid":false,"given":"Sylwia","family":"Ammoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1951-1025","authenticated-orcid":false,"given":"C. Oliver","family":"Hanemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,23]]},"reference":[{"key":"3131_CR1","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1016\/j.gim.2022.05.007","volume":"24","author":"SR Plotkin","year":"2022","unstructured":"Plotkin SR, Messiaen L, Legius E, Pancza P, Avery RA, Blakeley JO, et al. Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation. Genet Med. 2022;24:1967\u201377.","journal-title":"Genet Med"},{"key":"3131_CR2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/ajmg.a.34359","volume":"158A","author":"JO Blakeley","year":"2012","unstructured":"Blakeley JO, Evans DG, Adler J, Brackmann D, Chen R, Ferner RE, et al. Consensus recommendations for current treatments and accelerating clinical trials for patients with neurofibromatosis type 2. Am J Med Genet A. 2012;158A:24\u201341.","journal-title":"Am J Med Genet A"},{"key":"3131_CR3","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/ng.3688","volume":"48","author":"S Agnihotri","year":"2016","unstructured":"Agnihotri S, Jalali S, Wilson MR, Danesh A, Li M, Klironomos G, et al. The genomic landscape of schwannoma. Nat Genet. 2016;48:1339\u201348.","journal-title":"Nat Genet"},{"key":"3131_CR4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/978-3-031-29750-2_11","volume":"1416","author":"JZ Wang","year":"2023","unstructured":"Wang JZ, Nassiri F, Mawrin C, Zadeh G. Genomic Landscape of Meningiomas. Adv Exp Med Biol. 2023;1416:137\u201358.","journal-title":"Adv Exp Med Biol"},{"key":"3131_CR5","doi-asserted-by":"publisher","first-page":"106236","DOI":"10.1016\/j.clineuro.2020.106236","volume":"198","author":"C Champeaux-Depond","year":"2020","unstructured":"Champeaux-Depond C, Weller J, Resche-Rigon M. Neurofibromatosis type 2: a nationwide population-based study focused on survival after meningioma surgery. Clin Neurol Neurosurg. 2020;198:106236.","journal-title":"Clin Neurol Neurosurg"},{"key":"3131_CR6","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s11940-014-0308-3","volume":"16","author":"JT Jacob","year":"2014","unstructured":"Jacob JT, Link MJ, Pollock BE. Role of stereotactic radiosurgery in meningiomas and vestibular schwannomas. Curr Treat Options Neurol. 2014;16:308.","journal-title":"Curr Treat Options Neurol"},{"key":"3131_CR7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3171\/2014.7.JNS131644","volume":"122","author":"L Rogers","year":"2015","unstructured":"Rogers L, Barani I, Chamberlain M, Kaley TJ, McDermott M, Raizer J, et al. Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review. J Neurosurg. 2015;122:4\u201323.","journal-title":"J Neurosurg"},{"key":"3131_CR8","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.3171\/2016.11.JNS16498","volume":"133","author":"H Nakatomi","year":"2017","unstructured":"Nakatomi H, Jacob JT, Carlson ML, Tanaka S, Tanaka M, Saito N, et al. Long-term risk of recurrence and regrowth after gross-total and subtotal resection of sporadic vestibular schwannoma. J Neurosurg. 2017;133:1052\u201358.","journal-title":"J Neurosurg"},{"key":"3131_CR9","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1158\/0008-5472.CAN-16-2675","volume":"77","author":"M Vouri","year":"2017","unstructured":"Vouri M, Hafizi S. TAM receptor tyrosine kinases in cancer drug resistance. Cancer Res. 2017;77:2775\u20138.","journal-title":"Cancer Res"},{"key":"3131_CR10","doi-asserted-by":"publisher","first-page":"1843.","DOI":"10.3390\/cancers11121843","volume":"11","author":"N Al Kafri","year":"2019","unstructured":"Al Kafri N, Hafizi S. Tumour-secreted protein S (ProS1) activates a Tyro3-Erk signalling axis and protects cancer cells from apoptosis. Cancers (Basel). 2019;11:1843.","journal-title":"Cancers (Basel)"},{"key":"3131_CR11","doi-asserted-by":"publisher","first-page":"25698","DOI":"10.18632\/oncotarget.8365","volume":"7","author":"Y Jung","year":"2016","unstructured":"Jung Y, Decker AM, Wang J, Lee E, Kana LA, Yumoto K, et al. Endogenous GAS6 and Mer receptor signaling regulate prostate cancer stem cells in bone marrow. Oncotarget. 2016;7:25698\u2013711.","journal-title":"Oncotarget"},{"key":"3131_CR12","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/jcp.22955","volume":"227","author":"NB Caberoy","year":"2012","unstructured":"Caberoy NB, Alvarado G, Bigcas JL, Li W. Galectin-3 is a new MerTK-specific eat-me signal. J Cell Physiol. 2012;227:401\u20137.","journal-title":"J Cell Physiol"},{"key":"3131_CR13","doi-asserted-by":"publisher","first-page":"16183","DOI":"10.18632\/oncotarget.3952","volume":"6","author":"M Vouri","year":"2015","unstructured":"Vouri M, An Q, Birt M, Pilkington GJ, Hafizi S. Small molecule inhibition of Axl receptor tyrosine kinase potently suppresses multiple malignant properties of glioma cells. Oncotarget. 2015;6:16183\u201397.","journal-title":"Oncotarget"},{"key":"3131_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2016.66","volume":"5","author":"M Vouri","year":"2016","unstructured":"Vouri M, Croucher DR, Kennedy SP, An Q, Pilkington GJ, Hafizi S. Axl-EGFR receptor tyrosine kinase hetero-interaction provides EGFR with access to pro-invasive signalling in cancer cells. Oncogenesis. 2016;5:e266.","journal-title":"Oncogenesis"},{"key":"3131_CR15","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1172\/JCI22079","volume":"115","author":"A Angelillo-Scherrer","year":"2005","unstructured":"Angelillo-Scherrer A, Burnier L, Flores N, Savi P, DeMol M, Schaeffer P, et al. Role of Gas6 receptors in platelet signaling during thrombus stabilization and implications for antithrombotic therapy. J Clin Invest. 2005;115:237\u201346.","journal-title":"J Clin Invest"},{"key":"3131_CR16","doi-asserted-by":"publisher","first-page":"e36800","DOI":"10.1371\/journal.pone.0036800","volume":"7","author":"JE Brown","year":"2012","unstructured":"Brown JE, Krodel M, Pazos M, Lai C, Prieto AL. Cross-phosphorylation, signaling and proliferative functions of the Tyro3 and Axl receptors in Rat2 cells. PLoS One. 2012;7:e36800.","journal-title":"PLoS One"},{"key":"3131_CR17","first-page":"2619","volume":"11","author":"IC Taylor","year":"1995","unstructured":"Taylor IC, Roy S, Varmus HE. Overexpression of the Sky receptor tyrosine kinase at the cell surface or in the cytoplasm results in ligand-independent activation. Oncogene 1995;11:2619\u201326.","journal-title":"Oncogene"},{"key":"3131_CR18","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.oraloncology.2015.04.004","volume":"51","author":"KC Chiu","year":"2015","unstructured":"Chiu KC, Lee CH, Liu SY, Chou YT, Huang RY, Huang SM, et al. Polarization of tumor-associated macrophages and Gas6\/Axl signaling in oral squamous cell carcinoma. Oral Oncol. 2015;51:683\u20139.","journal-title":"Oral Oncol"},{"key":"3131_CR19","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/nature17630","volume":"532","author":"L Fourgeaud","year":"2016","unstructured":"Fourgeaud L, Traves PG, Tufail Y, Leal-Bailey H, Lew ED, Burrola PG, et al. TAM receptors regulate multiple features of microglial physiology. Nature. 2016;532:240\u20134.","journal-title":"Nature"},{"key":"3131_CR20","doi-asserted-by":"publisher","first-page":"564133","DOI":"10.3389\/fimmu.2020.564133","volume":"11","author":"P Giroud","year":"2020","unstructured":"Giroud P, Renaudineau S, Gudefin L, Calcei A, Menguy T, Rozan C, et al. Expression of TAM-R in human immune cells and unique regulatory function of MerTK in IL-10 production by tolerogenic DC. Front Immunol. 2020;11:564133.","journal-title":"Front Immunol"},{"key":"3131_CR21","doi-asserted-by":"publisher","first-page":"1850.","DOI":"10.3390\/cancers12071850","volume":"12","author":"M Tanaka","year":"2020","unstructured":"Tanaka M, Siemann DW. Gas6\/Axl signaling pathway in the tumor immune microenvironment. Cancers (Basel). 2020;12:1850.","journal-title":"Cancers (Basel)"},{"key":"3131_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2015.07.019","volume":"53","author":"P Domingues","year":"2016","unstructured":"Domingues P, Gonzalez-Tablas M, Otero A, Pascual D, Miranda D, Ruiz L, et al. Tumor infiltrating immune cells in gliomas and meningiomas. Brain Behav Immun. 2016;53:1\u201315.","journal-title":"Brain Behav Immun"},{"key":"3131_CR23","first-page":"vdz018","volume":"1","author":"DT Proctor","year":"2019","unstructured":"Proctor DT, Huang J, Lama S, Albakr A, Van Marle G, Sutherland GR. Tumor-associated macrophage infiltration in meningioma. Neurooncol Adv. 2019;1:vdz018.","journal-title":"Neurooncol Adv"},{"key":"3131_CR24","doi-asserted-by":"publisher","first-page":"2473974X2110591","DOI":"10.1177\/2473974X211059111","volume":"5","author":"E Nisenbaum","year":"2021","unstructured":"Nisenbaum E, Misztal C, Szczupak M, Thielhelm T, Pena S, Mei C, et al. Tumor-associated macrophages in vestibular schwannoma and relationship to hearing. OTO Open. 2021;5:2473974X211059111.","journal-title":"OTO Open"},{"key":"3131_CR25","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/MAO.0b013e31827c9fbf","volume":"34","author":"M de Vries","year":"2013","unstructured":"de Vries M, Briaire-de Bruijn I, Malessy MJ, de Bruine SF, van der Mey AG, Hogendoorn PC. Tumor-associated macrophages are related to volumetric growth of vestibular schwannomas. Otol Neurotol. 2013;34:347\u201352.","journal-title":"Otol Neurotol"},{"key":"3131_CR26","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/onc.2012.587","volume":"33","author":"S Ammoun","year":"2014","unstructured":"Ammoun S, Provenzano L, Zhou L, Barczyk M, Evans K, Hilton DA, et al. Axl\/Gas6\/NFkappaB signalling in schwannoma pathological proliferation, adhesion and survival. Oncogene. 2014;33:336\u201346.","journal-title":"Oncogene"},{"key":"3131_CR27","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/neup.12266","volume":"36","author":"DA Hilton","year":"2016","unstructured":"Hilton DA, Shivane A, Kirk L, Bassiri K, Enki DG, Hanemann CO. Activation of multiple growth factor signalling pathways is frequent in meningiomas. Neuropathology. 2016;36:250\u201361.","journal-title":"Neuropathology"},{"key":"3131_CR28","doi-asserted-by":"publisher","first-page":"eabm6247","DOI":"10.1126\/sciadv.abm6247","volume":"8","author":"JCT Bayley","year":"2022","unstructured":"Bayley JCT, Hadley CC, Harmanci AO, Harmanci AS, Klisch TJ, Patel AJ. Multiple approaches converge on three biological subtypes of meningioma and extract new insights from published studies. Sci Adv. 2022;8:eabm6247.","journal-title":"Sci Adv"},{"key":"3131_CR29","doi-asserted-by":"publisher","first-page":"951.","DOI":"10.15252\/msb.20177701","volume":"13","author":"M Frejno","year":"2017","unstructured":"Frejno M, Zenezini Chiozzi R, Wilhelm M, Koch H, Zheng R, Klaeger S, et al. Pharmacoproteomic characterisation of human colon and rectal cancer. Mol Syst Biol. 2017;13:951.","journal-title":"Mol Syst Biol"},{"key":"3131_CR30","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1038\/leu.2013.371","volume":"28","author":"SP Whitman","year":"2014","unstructured":"Whitman SP, Kohlschmidt J, Maharry K, Volinia S, Mrozek K, Nicolet D, et al. GAS6 expression identifies high-risk adult AML patients: potential implications for therapy. Leukemia. 2014;28:1252\u20138.","journal-title":"Leukemia"},{"key":"3131_CR31","doi-asserted-by":"publisher","first-page":"3420","DOI":"10.1038\/onc.2012.355","volume":"32","author":"RM Linger","year":"2013","unstructured":"Linger RM, Cohen RA, Cummings CT, Sather S, Migdall-Wilson J, Middleton DH, et al. Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancer. Oncogene. 2013;32:3420\u201331.","journal-title":"Oncogene"},{"key":"3131_CR32","doi-asserted-by":"publisher","first-page":"16346","DOI":"10.1523\/JNEUROSCI.0402-13.2013","volume":"33","author":"M Kokkinaki","year":"2013","unstructured":"Kokkinaki M, Abu-Asab M, Gunawardena N, Ahern G, Javidnia M, Young J, et al. Klotho regulates retinal pigment epithelial functions and protects against oxidative stress. J Neurosci. 2013;33:16346\u201359.","journal-title":"J Neurosci"},{"key":"3131_CR33","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/nar\/gkg147","volume":"31","author":"M Amarzguioui","year":"2003","unstructured":"Amarzguioui M, Holen T, Babaie E, Prydz H. Tolerance for mutations and chemical modifications in a siRNA. Nucleic Acids Res. 2003;31:589\u201395.","journal-title":"Nucleic Acids Res"},{"key":"3131_CR34","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1158\/0008-5472.CAN-20-3857","volume":"82","author":"EA Maze","year":"2022","unstructured":"Maze EA, Agit B, Reeves S, Hilton DA, Parkinson DB, Laraba L, et al. Human endogenous retrovirus type k promotes proliferation and confers sensitivity to antiretroviral drugs in merlin-negative schwannoma and meningioma. Cancer Res. 2022;82:235\u201347.","journal-title":"Cancer Res"},{"key":"3131_CR35","doi-asserted-by":"publisher","first-page":"i4","DOI":"10.1093\/neuonc\/noy178","volume":"21","author":"S Suppiah","year":"2019","unstructured":"Suppiah S, Nassiri F, Bi WL, Dunn IF, Hanemann CO, Horbinski CM, et al. Molecular and translational advances in meningiomas. Neuro Oncol. 2019;21:i4\u2013i17.","journal-title":"Neuro Oncol"},{"key":"3131_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/hmg\/ddu414","volume":"24","author":"JR Gehlhausen","year":"2015","unstructured":"Gehlhausen JR, Park SJ, Hickox AE, Shew M, Staser K, Rhodes SD, et al. A murine model of neurofibromatosis type 2 that accurately phenocopies human schwannoma formation. Hum Mol Genet. 2015;24:1\u20138.","journal-title":"Hum Mol Genet"},{"key":"3131_CR37","doi-asserted-by":"publisher","first-page":"6952","DOI":"10.1074\/jbc.M311750200","volume":"279","author":"C Heiring","year":"2004","unstructured":"Heiring C, Dahlback B, Muller YA. Ligand recognition and homophilic interactions in Tyro3: structural insights into the Axl\/Tyro3 receptor tyrosine kinase family. J Biol Chem. 2004;279:6952\u20138.","journal-title":"J Biol Chem"},{"key":"3131_CR38","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nrneurol.2011.82","volume":"7","author":"S Ammoun","year":"2011","unstructured":"Ammoun S, Hanemann CO. Emerging therapeutic targets in schwannomas and other merlin-deficient tumors. Nat Rev Neurol. 2011;7:392\u20139.","journal-title":"Nat Rev Neurol"},{"key":"3131_CR39","doi-asserted-by":"publisher","first-page":"3508","DOI":"10.4049\/jimmunol.1200662","volume":"189","author":"G Zizzo","year":"2012","unstructured":"Zizzo G, Hilliard BA, Monestier M, Cohen PL. Efficient clearance of early apoptotic cells by human macrophages requires M2c polarization and MerTK induction. J Immunol. 2012;189:3508\u201320.","journal-title":"J Immunol"},{"key":"3131_CR40","doi-asserted-by":"crossref","unstructured":"Adams CL, Ercolano E, Ferluga S, Sofela A, Dave F, Negroni C, et al. A rapid robust method for subgrouping non-NF2 meningiomas according to genotype and detection of lower levels of M2 macrophages in AKT1 E17K mutated tumours. Int J Mol Sci. 2020;21.","DOI":"10.3390\/ijms21041273"},{"key":"3131_CR41","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.redox.2015.08.009","volume":"6","author":"F Vannini","year":"2015","unstructured":"Vannini F, Kashfi K, Nath N. The dual role of iNOS in cancer. Redox Biol. 2015;6:334\u201343.","journal-title":"Redox Biol"},{"key":"3131_CR42","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00795-017-0165-8","volume":"51","author":"C Ma","year":"2018","unstructured":"Ma C, Horlad H, Ohnishi K, Nakagawa T, Yamada S, Kitada S, et al. CD163-positive cancer cells are potentially associated with high malignant potential in clear cell renal cell carcinoma. Med Mol Morphol. 2018;51:13\u201320.","journal-title":"Med Mol Morphol"},{"key":"3131_CR43","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1093\/neuonc\/not028","volume":"15","author":"H Kanno","year":"2013","unstructured":"Kanno H, Nishihara H, Wang L, Yuzawa S, Kobayashi H, Tsuda M, et al. Expression of CD163 prevents apoptosis through the production of granulocyte colony-stimulating factor in meningioma. Neuro Oncol. 2013;15:853\u201364.","journal-title":"Neuro Oncol"},{"key":"3131_CR44","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/ni.2705","volume":"14","author":"LC Davies","year":"2013","unstructured":"Davies LC, Jenkins SJ, Allen JE, Taylor PR. Tissue-resident macrophages. Nat Immunol. 2013;14:986\u201395.","journal-title":"Nat Immunol"},{"key":"3131_CR45","doi-asserted-by":"publisher","first-page":"e3000159","DOI":"10.1371\/journal.pbio.3000159","volume":"17","author":"LA Green","year":"2019","unstructured":"Green LA, Nebiolo JC, Smith CJ. Microglia exit the CNS in spinal root avulsion. PLoS Biol. 2019;17:e3000159.","journal-title":"PLoS Biol"},{"key":"3131_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/srep12910","volume":"5","author":"D Lukovic","year":"2015","unstructured":"Lukovic D, Artero Castro A, Delgado AB, Bernal Mde L, Luna Pelaez N, Diez Lloret A, et al. Human iPSC derived disease model of MERTK-associated retinitis pigmentosa. Sci Rep. 2015;5:12910.","journal-title":"Sci Rep."},{"key":"3131_CR47","doi-asserted-by":"publisher","first-page":"102366","DOI":"10.1016\/j.redox.2022.102366","volume":"54","author":"Y Liu","year":"2022","unstructured":"Liu Y, Lan L, Li Y, Lu J, He L, Deng Y, et al. N-glycosylation stabilizes MerTK and promotes hepatocellular carcinoma tumor growth. Redox Biol. 2022;54:102366.","journal-title":"Redox Biol"},{"key":"3131_CR48","doi-asserted-by":"publisher","first-page":"25750","DOI":"10.1074\/jbc.M114.569020","volume":"289","author":"WI Tsou","year":"2014","unstructured":"Tsou WI, Nguyen KQ, Calarese DA, Garforth SJ, Antes AL, Smirnov SV, et al. Receptor tyrosine kinases, TYRO3, AXL, and MER, demonstrate distinct patterns and complex regulation of ligand-induced activation. J Biol Chem. 2014;289:25750\u201363.","journal-title":"J Biol Chem"},{"key":"3131_CR49","doi-asserted-by":"publisher","first-page":"114113","DOI":"10.1016\/j.bcp.2020.114113","volume":"178","author":"L Wang","year":"2020","unstructured":"Wang L, Li YS, Yu LG, Zhang XK, Zhao L, Gong FL, et al. Galectin-3 expression and secretion by tumor-associated macrophages in hypoxia promotes breast cancer progression. Biochem Pharm. 2020;178:114113.","journal-title":"Biochem Pharm"},{"key":"3131_CR50","doi-asserted-by":"crossref","unstructured":"Al Kafri N, Hafizi S. Galectin-3 stimulates Tyro3 receptor tyrosine kinase and ERK signalling, cell survival and migration in human cancer cells. Biomolecules. 2020;10.","DOI":"10.3390\/biom10071035"},{"key":"3131_CR51","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1182\/blood-2009-06-228684","volume":"115","author":"S Loges","year":"2010","unstructured":"Loges S, Schmidt T, Tjwa M, van Geyte K, Lievens D, Lutgens E, et al. Malignant cells fuel tumor growth by educating infiltrating leukocytes to produce the mitogen Gas6. Blood. 2010;115:2264\u201373.","journal-title":"Blood"},{"key":"3131_CR52","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","volume":"79","author":"DC Hinshaw","year":"2019","unstructured":"Hinshaw DC, Shevde LA. THE TUMOR MICROENVIRONMENT INNATELY MODULATES CANCER PRogression. Cancer Res. 2019;79:4557\u201366.","journal-title":"Cancer Res"},{"key":"3131_CR53","doi-asserted-by":"crossref","unstructured":"Arneth B. Tumor microenvironment. Medicina (Kaunas). 2019;56.","DOI":"10.3390\/medicina56010015"},{"key":"3131_CR54","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.mcn.2006.06.011","volume":"33","author":"D Prasad","year":"2006","unstructured":"Prasad D, Rothlin CV, Burrola P, Burstyn-Cohen T, Lu Q, Garcia de Frutos P, et al. TAM receptor function in the retinal pigment epithelium. Mol Cell Neurosci. 2006;33:96\u2013108.","journal-title":"Mol Cell Neurosci"},{"key":"3131_CR55","doi-asserted-by":"publisher","first-page":"3486","DOI":"10.1093\/emboj\/cdg359","volume":"22","author":"IM Nooren","year":"2003","unstructured":"Nooren IM, Thornton JM. Diversity of protein-protein interactions. EMBO J. 2003;22:3486\u201392.","journal-title":"EMBO J"},{"key":"3131_CR56","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.cell.2010.06.011","volume":"141","author":"MA Lemmon","year":"2010","unstructured":"Lemmon MA, Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell. 2010;141:1117\u201334.","journal-title":"Cell"},{"key":"3131_CR57","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/sj.emboj.7600912","volume":"25","author":"T Sasaki","year":"2006","unstructured":"Sasaki T, Knyazev PG, Clout NJ, Cheburkin Y, Gohring W, Ullrich A, et al. Structural basis for Gas6-Axl signalling. EMBO J. 2006;25:80\u20137.","journal-title":"EMBO J"},{"key":"3131_CR58","doi-asserted-by":"publisher","first-page":"5872","DOI":"10.1038\/onc.2016.120","volume":"35","author":"CW Chien","year":"2016","unstructured":"Chien CW, Hou PC, Wu HC, Chang YL, Lin SC, Lin SC, et al. Targeting TYRO3 inhibits epithelial-mesenchymal transition and increases drug sensitivity in colon cancer. Oncogene. 2016;35:5872\u201381.","journal-title":"Oncogene"},{"key":"3131_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1022-2","volume":"18","author":"KV Myers","year":"2019","unstructured":"Myers KV, Amend SR, Pienta KJ. Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment. Mol Cancer. 2019;18:94.","journal-title":"Mol Cancer"},{"key":"3131_CR60","doi-asserted-by":"publisher","first-page":"e12766","DOI":"10.1111\/nan.12766","volume":"48","author":"JAR Nicoll","year":"2022","unstructured":"Nicoll JAR, Bloom T, Clarke A, Boche D, Hilton D. BRAIN UK: accessing NHS tissue archives for neuroscience research. Neuropathol Appl Neurobiol. 2022;48:e12766.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"3131_CR61","doi-asserted-by":"publisher","first-page":"1744.","DOI":"10.3390\/cancers12071744","volume":"12","author":"J Lyons Rimmer","year":"2020","unstructured":"Lyons Rimmer J, Ercolano E, Baiz D, Makhija M, Berger A, Sells T, et al. The potential of MLN3651 in combination with selumetinib as a treatment for merlin-deficient meningioma. Cancers (Basel). 2020;12:1744.","journal-title":"Cancers (Basel)"},{"key":"3131_CR62","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1093\/brain\/awac342","volume":"146","author":"L Laraba","year":"2023","unstructured":"Laraba L, Hillson L, de Guibert JG, Hewitt A, Jaques MR, Tang TT, et al. Inhibition of YAP\/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma. Brain. 2023;146:1697\u2013713.","journal-title":"Brain"},{"key":"3131_CR63","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s40478-023-01677-9","volume":"11","author":"LL van de Weijer","year":"2023","unstructured":"van de Weijer LL, Ercolano E, Zhang T, Shah M, Banton MC, Na J, et al. A novel patient-derived meningioma spheroid model as a tool to study and treat epithelial-to-mesenchymal transition (EMT) in meningiomas. Acta Neuropathol Commun. 2023;11:198.","journal-title":"Acta Neuropathol Commun"},{"key":"3131_CR64","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)). Methods. 2001;25:402\u20138.","journal-title":"Methods"},{"key":"3131_CR65","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1128\/MCB.25.6.2384-2394.2005","volume":"25","author":"GH Xiao","year":"2005","unstructured":"Xiao GH, Gallagher R, Shetler J, Skele K, Altomare DA, Pestell RG, et al. The NF2 tumor suppressor gene product, merlin, inhibits cell proliferation and cell cycle progression by repressing cyclin D1 expression. Mol Cell Biol. 2005;25:2384\u201394.","journal-title":"Mol Cell Biol"},{"key":"3131_CR66","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9:676\u201382.","journal-title":"Nat Methods"},{"key":"3131_CR67","doi-asserted-by":"publisher","first-page":"6132","DOI":"10.1038\/onc.2017.200","volume":"36","author":"L Provenzano","year":"2017","unstructured":"Provenzano L, Ryan Y, Hilton DA, Lyons-Rimmer J, Dave F, Maze EA, et al. Cellular prion protein (PrP(C)) in the development of Merlin-deficient tumours. Oncogene. 2017;36:6132\u201342.","journal-title":"Oncogene"},{"key":"3131_CR68","doi-asserted-by":"publisher","first-page":"7031","DOI":"10.1021\/jm500749d","volume":"57","author":"W Zhang","year":"2014","unstructured":"Zhang W, DeRyckere D, Hunter D, Liu J, Stashko MA, Minson KA, et al. UNC2025, a potent and orally bioavailable MER\/FLT3 dual inhibitor. J Med Chem. 2014;57:7031\u201341.","journal-title":"J Med Chem"},{"key":"3131_CR69","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1158\/0008-5472.CAN-09-2997","volume":"70","author":"SJ Holland","year":"2010","unstructured":"Holland SJ, Pan A, Franci C, Hu Y, Chang B, Li W, et al. R428, a selective small molecule inhibitor of Axl kinase, blocks tumor spread and prolongs survival in models of metastatic breast cancer. Cancer Res. 2010;70:1544\u201354.","journal-title":"Cancer Res"},{"key":"3131_CR70","doi-asserted-by":"publisher","first-page":"3517","DOI":"10.1007\/s11033-014-3215-5","volume":"41","author":"L Wu","year":"2014","unstructured":"Wu L, Hu X, Tang H, Han Z, Chen Y. Valid application of western blotting. Mol Biol Rep. 2014;41:3517\u201320.","journal-title":"Mol Biol Rep."}],"updated-by":[{"DOI":"10.1038\/s41388-024-03177-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T00:00:00Z","timestamp":1727308800000}}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-024-03131-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-024-03131-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-024-03131-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T10:02:19Z","timestamp":1728295339000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-024-03131-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,23]]},"references-count":70,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2024,10,7]]}},"alternative-id":["3131"],"URL":"https:\/\/doi.org\/10.1038\/s41388-024-03131-z","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41388-024-03177-z","asserted-by":"object"}]},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,23]]},"assertion":[{"value":"5 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2024","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41388-024-03177-z","URL":"https:\/\/doi.org\/10.1038\/s41388-024-03177-z","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Participants provided written informed consent and the study was conducted in accordance with the Declaration of Helsinki under institutional review board approval (Plymouth Brain Tumour Biobank, REC No: 19\/SC\/0267, IRAS project ID: 246667; Reference:15\/011 and 14\/015).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}